eXoZymes, Inc. (EXOZ)
$5.25-0.38%Close
SELLCRISIS · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $49M
- Beta
- 3.19
- P/E (TTM)
- -4.60
- Short % float
- 0.75%
- Days to cover
- 2.0
- SI change
- -9.6%
- 1W
- -9.01%
- 1M
- -14.91%
- vs SPY 1W
- -10.17%
- vs SPY 1M
- -17.90%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on EXOZ?
- LOPJLB’s latest quantitative signal on eXoZymes, Inc. (EXOZ) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is EXOZ in?
- eXoZymes, Inc. (EXOZ) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does eXoZymes, Inc. (EXOZ) do?
- eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.